WR Biotech, LLC

Tampa, FL · Medtech · Private

Improved Synchronization Modulation Electric Field (i-SMEF) technology for donor heart preservation during cold storage

Grants
$2.9M
4 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
3
1 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Protection of donor kidneys with synchronization modulation electric field (SMEF)$251,260
Federal grantDepartment of Health and Human Services · Phase II · Protection of donor kidneys with synchronization modulation electric field (SMEF)$1,607,477
Federal grantDepartment of Health and Human Services · Phase II · Protection of donor kidneys with synchronization modulation electric field (SMEF)$804,164
Federal grantDepartment of Health and Human Services · Phase I · Protection of transplanted heart function by regulation of Na/K pump activity$275,739
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1608CereVu Medical, Inc.——
1609TREYSTA MEDICAL TECHNOLOGIES INC—$183K
1610AROMHA, INC.—$425K
1611WR Biotech, LLC——
1612Buck Surgical, Inc.—$300K
1613NeoTherma Oncology Inc.——
1614VYLUMA INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 1 granted of 3

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.